Why Abzena?
Our focused approach.
Streamlining your program from early phase development to commercialization, mitigating project risk and producing a quality medicine, Abzena is an industry leader in the development, scaling and manufacture of small molecule intermediates including high potency chemistry, payloads, linkers, payload-linker chemical intermediates, bioconjugation and antibody drug conjugates (ADCs).
Wherever your molecule is in its development, we have the agility and capability to support technology transfer, process optimization, and full process development capabilities.
We have a proven track record of producing a wide range of molecules from the most straightforward to very complex modalities:
We are committed to achieving quality excellence. We’re transparent in our communications and work collaboratively to progress your programs and keep them on track.